Oncologists caution that at-home genetic tests taken up by millions of Americans looking to gauge their cancer risk are not ...

Ask yourself how the genetic test results may affect your life. If the results come back positive, will you take steps to ...

The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

The National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care-;announces the publication of ...

Relevant genes to test for hereditary prostate cancer include ATM, BRCA1, BRCA2, CHEK2, HOXB13, and TP53, according to the guidelines. For all four cancer types included in these guidelines, NCCN also ...

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

Colorectal, Endometrial, and Gastric. Additional cancer types were added to the title and content for both guidelines. These ...

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive ...

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.

A prospective cross-section study by BGI Genomics and Siriraj Hospital demonstrates high accuracy of multitarget stool DNA testing for colorectal cancer detection in Thai individuals, offering a ...